UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934 Date of Report
(Date of earliest reported) November 14, 2000
HEALTHEXTRAS, INC.
(Exact name of registrant as specified in its charter)
Delaware 1-15535 52-2181356
-------- -------- ----------
(State or other jurisdiction of (Commission (IRS Employer
incorporation or organization) File Number) Identification No.)
2273 Research Boulevard, 2nd Floor, Rockville, Maryland 20850
-------------------------------------------------------------
(Address of principal executive offices, zip code)
(301) 548-2900
(Registrant's phone number, including area code)
Not Applicable
--------------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report)
Item 5. OTHER EVENTS
On November 14, 2000, HealthExtras, Inc. (the "Company") issued a press
release, which reported that it had acquired a controlling interest in
International Pharmacy Management, Inc. A copy of this press release is attached
as Exhibit 99.1 A copy of the related Securities Purchase Agreement is attached
as Exhibit 10.11
Item 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits. (Filed Herewith)
Exhibit No. Description
----------- ------------
10.11 Securities Purchase Agreement by and among
HealthExtras, Inc. as the Purchaser and TD
Javelin Capital Fund, L.P., Meriken Nominees, LTD,
et al. as the Sellers
99.1 IPM Press Release
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
HEALTHEXTRAS, INC.
Date: November 21, 2000 By: /s/ Michael P. Donovan
-------------------------------
Michael P. Donovan
Chief Financial Officer and
Chief Accounting Officer